Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

TB/HIV Research Priorities in Resource-Limited Settings: Report of an Expert Consultation

Report
TB/HIV Research Priorities in Resource-Limited Settings: Report of an Expert Consultation

This report is an outline of the Expert Consultation on TB/HIV Research Priorities in Resource-limited Setting on 14-16 February 2005 in Geneva, Switzerland. Three discussion groups identified research priorities for five major areas: (1) preventive therapy for TB were identified with a distinction between the population and the individual levels; (2) co-trimoxazole prophylaxis including the role of co-trimoxazole in the context of antiretroviral therapy, delivery strategies, and determining the efficacy of and optimal time for initiating co-trimoxazole prophylaxis among people living with HIV/AIDS and TB; (3) antiretroviral therapy for people living with HIV/AIDS who have TB or who develop TB is validating the optimal time for initiating antiretroviral therapy; (4) intensified case-finding focus on ways to put this TB/HIV collaborative activity into operation to improve TB control; and (5) the development of new tools and diagnostic algorithms to improve the diagnosis of smear-negative TB in adults and children.

Author:

Scano, F.

Audiences:

Policy Makers

Topic:

Advocacy/Communications, HIV Co-infection, Partnership Building

Related Materials

Priority Research Questions for TB/HIV in HIV-Prevalent and Resource-Limited Settings

This document is intended to raise awareness about TB/HIV research priorities (i.e. areas that require urgent funding and scientific interest), help coordinate advocacy efforts, and encourage research funding. The aim is to increase the implementation of high-quality, integrated TB/HIV interventions in resource-limited settings. The document outlines a revised research priority agenda based on the latest evidence in six key areas of TB and HIV co-infection.

Report

Guidelines for the Prevention of Tuberculosis in Health Care Facilities in Resource-Limited Settings

This guideline presents information about the prevention of TB in health care facilities.

Guideline

Report of an Expert Consultation on the Uses of Nucleic Acid Amplification Tests for the Diagnosis of Tuberculosis

This report on the uses of nucleic acid amplification (NAA) tests for diagnosis of TB is based on contributions of an expert panel of consultants convened by the Centers for Disease Control and Prevention (CDC) and the Association of Public Health Laboratories (APHL). The report presents the background for the study; general considerations, such as optimum patient care and public health, the value of NAA testing for clinicians and TB control officials, limitations of the tests, costs and funding issues, and turnaround time; research needs; available information on molecular drug susceptibility tests; the general recommendations of the panel; the communication plan for the new recommendations; and recommendations to the Advisory Council for the Elimination of TB (ACET), CDC, and the Division of TB Elimination (DTBE). The recommendations included the following: that all U.S. clinicians and public health TB programs should have access to molecular tests to aid in the diagnosis of TB and that NAA testing for TB should become standard practice for TB suspects.

Report

Global resources for the prevention,
management, and elimination of TB.